The company currently lists several treatment categories, including compounded semaglutide, compounded tirzepatide, sermorelin, NAD+ vial, NAD+ spray, and lipotropic MIC + B12 injections
A separate 2025 narrative review confirmed three total published human pilot studies and noted that no major adverse events were reported across those pilots [15]
It's important to note that long-term use of certain diabetes medications, including GLP-1 receptor agonists like semaglutide, may be associated with an increased risk of vitamin B12 deficiency [1]
It has been studied for its potential to enhance immune responses and may have applications in treating infections and certain cancers
A blood test tells you where you actually stand
In the Womens Intervention Nutrition Study, where participants in the intervention arm lost an average of 2.7 kg more than those in the control group, there was a significant improvement in relapse-free survival (HR, 0.76